Search Results
You searched for "Merck" ( 317 results )
-
Brinc announces partnership with Fusang, Asia's first fully regulated digital asset exchange
To make startup investment more inclusive through security tokenization and on-chain solutions Brinc becomes a shareholder in Fusang Corp, furthering a relationship that also sees Fusang coming onboard as a program partner for ZK Advancer (formerly Launchpad Luna), the accelerator launched by Brinc and Animoca Brands ZK Advancer participants will gain access to Fusang's industry expertise, personalized mentorship, and its single platform tokenization solution Participants may also lis
PR Newswire Oct. 18, 2022
-
PharmAbcine Announces Poster Presentations on Its anti-VISTA Antibody Candidate at SITC 2022
DAEJEON, South Korea, Oct. 17, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the Company will present preclinical data of PMC-309, one of the Company's first immuno-oncology drug candidates, at SITC (Society for Immunotherapy of Cancer) Annual Meeting taking place November 8-12 in Boston. On November 7, the abstract of the presentation will be made
PR Newswire Oct. 17, 2022
-
Celonis Introduces New Perspectives for Business Execution at Celosphere 2022 on November 9 - 10 in Munich, Germany
NEW YORK and MUNICH, Oct. 13, 2022 /PRNewswire/ -- Celonis, the global leader in execution management, today announced that the world's top process mining and execution management experts will convene at Celosphere 2022 in Munich, Germany on November 9 -10. The two-day Celosphere experience is designed from the ground up to create unique curated experiences and to mobilize the top process professionals on earth with the most advanced process and business execution technologies. Attendees w
PR Newswire Oct. 14, 2022
-
BEYOND EXPO 2022 MAKES HISTORY! HERE'S A SUCCESSFUL RECAP OF THE WORLD'S LARGEST TECH EXPO IN THE METAVERSE
BEIJING, Oct. 13, 2022 /PRNewswire/ -- From the number of participants to the extensive list of participating companies, BEYOND Expo 2022 has made history by hosting the largest international tech expo in the metaverse. BEYOND Expo 2022 Closing Remarks From September 21st – 27th, BEYOND Expo 2022 brought together over 35,000 participants, exhibitors, media representatives, enterprises, and government agencies from more than 120 countries into the metaverse to create a brand-new intera
PR Newswire Oct. 13, 2022
-
BEYOND Expo | Merck China president Allan Gabor shares insights on AI and biomedicine
BEIJING, Sept. 26, 2022 /PRNewswire/ -- In his speech during Wednesday's virtual event, Allan Gabor, president of Merck China and executive vice president of Merck Electronics, shared his insights on the AI and biomedicine industry and further explained how the firm uses AI to accelerate the biotech industry in healthcare, life sciences, and electronics. Allan Gabor, president of Merck China and executive vice president of Merck Electronics, talks at BEYOND Expo. On Wednesday, the BEY
PR Newswire Sept. 27, 2022
-
Top healthcare executive sets up fundraising platform matching healthcare startups to medical investors
Chris Lee aims to transform healthcare fundraising through VentureBlick's fundraising platform and professional community SINGAPORE, Sept. 1, 2022 /PRNewswire/ -- Chris Lee, one of the most experienced healthcare executives having held senior positions including president of Medtronic Asia Pacific and head of Bayer Healthcare Asia Pacific, today announced his new role as the founder and CEO of VentureBlick, a platform aiming to transform healthcare fundraising by matching healthcare startups
PR Newswire Sept. 1, 2022
-
Postech chip professor wins Merck Award
Professor Noh Yong-Young of Postech won an annual award given by Merck Korea in recognition of his innovative research into the development of semiconducting materials for backplane thin-film transistor technology of organic light-emitting diode displays. His research, Merck Korea says, could contribute to the commercialization of backplane p-type thin-film transistors for high-performance OLED displays if further developed. The Merck Young Scientist Award went to professor Kang Suk-ku for prop
Technology Aug. 25, 2022
-
AVELOS THERAPEUTICS ANNOUNCES $8 MILLON SERIES A FUNDING ROUND
Seoul-Based Biotechnology Company to Use Financing for Expanding Oncology Drug Discovery and Development SEOUL, South Korea, Aug. 22, 2022 /PRNewswire/ -- Innovative biotechnology company specializing in new drug discovery and development, Avelos Therapeutics, has received a glowing endorsement from the venture capital community by raising $8 million in the startup's Series A funding round. The funding will support the company's targeted, biomarker-driven onco-therapeutics that aim to target c
PR Newswire Aug. 22, 2022
-
Standigm names Carl Foster chief business officer to expand strategic partnerships for AI drug discovery
Veteran biotech and pharmaceutical executive will help company increase its growth and international impact SEOUL, South Korea, Aug. 18, 2022 /PRNewswire/ -- Standigm Inc. ("Standigm"), the leading workflow artificial intelligence (AI) drug discovery company, today announced the appointment of Chief Business Officer Carl Foster. Based in our U.S. office, Foster will be responsible for expanding strategic partnerships for novel drug target discoveries and first-in-class lead ca
PR Newswire Aug. 18, 2022
-
Merck to acquire Mecaro’s chemical biz for 110m euros
German electronics technology firm Merck announced Wednesday that it has signed a deal to acquire the semiconductor-grade industrial gas and chemical operation of Korea-based listed company Mecaro for 110 million euros ($111.9 million). The transaction will involve business assets dedicated to chemical precursors used in thin film deposition for semiconductors, as well as some 100 employees. Mecaro is expected to split off the chemical business for the deal. The cash deal is expected to be clo
Industry Aug. 17, 2022
-
Starpharma signs new DEP® agreement with MSD
MELBOURNE, Australia, Aug. 10, 2022 /PRNewswire/ -- Australian biotechnology company Starpharma today announced it has signed a new DEP® Research Agreement with MSD, the trade name of Merck Sharp & Dohme LLC, Rahway, NJ, USA. This new DEP® program will generate and evaluate additional DEP® Antibody Drug Conjugates (ADCs). This new agreement follows an earlier DEP® Antibody Drug Conjugate (ADC) agreement that Starpharma signed with MSD in February 2021 as well as an e
PR Newswire Aug. 10, 2022
-
Merck Becomes One of the First CDMOs to Provide Full Viral Vector Offering with Launch of VirusExpress® 293 Adeno-Associated Virus Production Platform
Reduces process development time by an estimated 40 percent Enables biopharmaceutical companies to increase the speed to clinical manufacturing Adds to company's best-in-class VirusExpress® Lentiviral Production Platform DARMSTADT, Germany, Aug. 9, 2022 /PRNewswire/ -- Merck, a leading science and technology company, has launched the VirusExpress® 293 Adeno-Associated Virus (AAV) Production Platform, making it one of the first CDMOs and technology-developers to provide a f
PR Newswire Aug. 9, 2022
-
Samsung Biologics Reports Second Quarter 2022 Financial Results
Released consolidated financial position of the company based on its full acquisition of Samsung Bioepis completed on April 20, 2022 Achieved record-high semi-annual revenue exceeding KRW 1 trillion Recorded Q2'22 revenue of KRW 503.7 billion for the company's CDMO business Recorded Q2'22 revenue of KRW 232.8 billion for Samsung Bioepis's biosimilars business Business operations remain stable with expanded base for future growth INCHEON, South Korea, July 27, 2022 /PRNewswire/
PR Newswire July 27, 2022
-
S. Korea is slow on consuming COVID-19 pills
South Korea is slow on consuming COVID-19 pills, yet the government earlier announced that it would secure additional pills in the future, government data showed Friday. The government expects that its increased number of one-stop COVID-19 treatment centers -- where people can take virus tests, get in-person medical care services and receive antiviral drugs -- would increase accessibility to COVID-19 pills. However, the COVID-19 pill use was still low. According to government data, the count
Social Affairs July 22, 2022
-
DayDayCook and Brinc commit to investing in 45 food tech companies that impact global food sustainability goals through the Good Food Accelerator Program
DayDayCook and Brinc join forces to invest US$10 million over the next three years through the Good Food Accelerator Program. Applications for the next cohort open on July 21, 2022. DayDayCook and Brinc share a dedicated mission to tackle global food sustainability goals by developing sustainable food systems and addressing food security issues in China and Asia. Prominent advisors and professional mentors from the food technology industry joining this program include: Patrick Kwok (Nis
PR Newswire July 21, 2022
-
Micron to Select Athinia™ for Pioneering Data Collaboration
A long-term, strategic, enterprise-level technology collaboration aims to further increase production efficiencies and reduce costs for Micron and its suppliers CAMBRIDGE, Mass., July 19, 2022 /PRNewswire/ -- Today, Athinia™ announced that Micron Technology, Inc. (Nasdaq: MU), a global leader in innovative memory and storage solutions, plans to use the Athinia™ data analytics platform to create a pioneering data collaboration ecosystem that will help lead a continued journey of dig
PR Newswire July 19, 2022
-
Cargene Biopharma Welcomes Kathy He as CEO, to Accelerate Novel Oligonucleotide Therapeutics Development
SINGAPORE, BOSTON and SHANGHAI, June 28, 2022 /PRNewswire/ -- Cargene Biopharma Inc. ("Cargene", the "Company"), a biopharmaceutical company developing oligonucleotide therapeutics for liver and ophthalmic disorders, is excited to welcome Kathy He, a seasoned biopharmaceutical industry executive, to join the Company as Chief Executive Officer and a member of the board. Kathy brings over 20 years of R&D and commercial experience from multiple global companies to her new
PR Newswire June 28, 2022
-
Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies
Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs) Merck now one of industry's largest manufacturers of these components globally Builds on company's 30 years' CDMO experience with multi-step, complex, and highly potent compounds DARMSTADT, Germany, June 23, 2022 /PRNewswire/ -- Merck, a leading science and technology company, announced that its Life Science business sector has doubled its high-potent active pharmaceutical ingredients (HPA
PR Newswire June 23, 2022
-
BIO Asia-Taiwan 2022 kicks off July 27 with theme 'Connecting the Asian Value Chain'
TAIPEI, June 14, 2022 /PRNewswire/ -- During a press event on June 8, 2022, the Taiwan Bio Industry Organization (Taiwan BIO) and the global Biotechnology Innovation Organization (BIO) announced updates to BIO Asia–Taiwan 2022 Onsite + Online International Conference and Exhibition, to be held in Taipei, Taiwan, July 27 to 31. With the theme 'Connecting the Asian Value Chain', the event will take place in both onsite and online formats to allow for greater international participation.
PR Newswire June 14, 2022
-
Standigm Signs MOU with Merck Korea for AI drug Discovery Research
- Merck's retrosynthesis AI software 'SYNTHIA™ retrosynthesis software' accelerates Standigm's synthesis capability SEOUL, South Korea, June 9, 2022 /PRNewswire/ -- Standigm Inc. ("Standigm"), the leading workflow artificial intelligence (AI) drug discovery company, today announced the signing of a Memorandum of Understanding (MOU) with Merck Korea, for AI-based drug discovery research. The MOU signing took place on May 30 at the headquarters of Standigm, attended by
PR Newswire June 9, 2022
Most Popular
-
1
Seoul vows action over Naver's Line, Yahoo dispute
-
2
[KH Explains] Hyundai Motor’s plan for new landmark keeps hitting bumps
-
3
Key S. Korean, USFK special operations officials to hold rare meeting amid NK threats
-
4
[Grace Kao] American racism against Stray Kids
-
5
Samsung doubles down on Vietnam
-
6
In Beijing, S. Korean top diplomat aims to jumpstart ties with China
-
7
NewJeans' members' parents complained to Hybe, email shows
-
8
Controversy brews over shakeup of prosecutors amid probe of first lady
-
9
Suspect behind murder of Korean tourist in Pattaya arrested
-
10
Prosecutors summon pastor involved in Dior bag scandal